{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T08:46:39Z","timestamp":1648975599065},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:00:00Z","timestamp":1456963200000},"content-version":"vor","delay-in-days":368,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jacc.2014.11.055","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T20:45:43Z","timestamp":1424724343000},"page":"816-819","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stent Selection and Antiplatelet\u00a0Therapy\u00a0Duration"],"prefix":"10.1016","volume":"65","author":[{"given":"David E.","family":"Kandzari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2014.11.055_bib1","unstructured":"Tillman DB. Approval order for endeavor zotarolimus-eluting coronary stent on the Over-the-Wire (OTW), Rapid Exchange (RX), or Multi Exchange II (MX2) Stent Delivery Systems - P060033. U.S. Food and Drug Administration. February 1, 2008. Available at: http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf6\/p060033a.pdf. Accessed December 5,\u00a02014."},{"key":"10.1016\/j.jacc.2014.11.055_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcin.2010.12.014","volume":"4","author":"Kandzari","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2014.11.055_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcin.2012.12.123","article-title":"The \u201cfinal\u201d five-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent","volume":"6","author":"Kirtane","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2014.11.055_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jcin.2012.12.125","article-title":"Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first generation drug-eluting and bare metal stents","volume":"6","author":"Kandzari","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2014.11.055_bib5","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(10)60208-5","article-title":"Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomized controlled superiority trial","volume":"375","author":"Rasmussen","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.11.055_bib6","article-title":"European data raise safety questions about Endeavor stent","author":"O\u2019Riordan","year":"2008","journal-title":"Medscape"},{"key":"10.1016\/j.jacc.2014.11.055_bib7","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)60405-0","article-title":"Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial","volume":"383","author":"Maeng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.11.055_bib8","unstructured":"Camenzind E, Steg PG, Mauri L, et\u00a0al., for the PROTECT Investigators. PROTECT: final five year results from the randomized drug eluting stent trial PROTECT: the Patient Related Outcomes wiTh Endeavor versus Cypher stenting Trial. Paper presented at: European Society of Cardiology Congress; September 2, 2014; Barcelona, Spain."},{"key":"10.1016\/j.jacc.2014.11.055_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcin.2010.02.008","article-title":"Optical coherence tomography assessment of in\u00a0vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents","volume":"3","author":"Guagliumi","year":"2010","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2014.11.055_bib10","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jacc.2009.01.051","article-title":"A\u00a0prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent. Differential recovery of coronary endothelial function","volume":"53","author":"Kim","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.11.055_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jcin.2011.06.017","article-title":"Dual\u00a0antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents","volume":"4","author":"Kandzari","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2014.11.055_bib12","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A\u00a0new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.11.055_bib13","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.11.055_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2014.11.053","article-title":"Zotarolimus-eluting versus bare-metal stents in\u00a0uncertain drug-eluting stent candidates","volume":"65","author":"Valgimigli","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.11.055_bib15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jama.2009.205","article-title":"Scientific evidence underlying the ACC\/AHA clinical practice guidelines","volume":"301","author":"Tricoci","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.11.055_bib16","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.11.055_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","article-title":"Clopidogrel use and long-term outcomes after drug-eluting stent implantation","volume":"10","author":"Eisenstein","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.11.055_bib18","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and\u00a0Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.11.055_bib19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/eurheartj\/ehi135","article-title":"Stent thrombosis following bare metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome","volume":"26","author":"Wenaweser","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.11.055_bib20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ahj.2005.08.011","article-title":"Bare metal stent restenosis is not a benign clinical entity","volume":"151","author":"Chen","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.11.055_bib21","unstructured":"ClinicalTrials.gov. The Dual Antiplatelet Therapy Study (DAPT Study). September 14, 2009. Updated November 14, 2014. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00977938. Accessed December 5,\u00a02014."},{"key":"10.1016\/j.jacc.2014.11.055_bib22","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.11.055_bib23","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/eurheartj\/ehu026","article-title":"Lack\u00a0of\u00a0association between dual antiplatelet therapy use and stent thrombosis between 1 and\u00a012 months following resolute zotarolimus-eluting stent implantation","volume":"35","author":"Silber","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.11.055_bib24","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive\u00a0network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.11.055_bib25","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.2013.278787","article-title":"Risk\u00a0of major adverse cardiac events following noncardiac surgery in patients with coronary stents","volume":"310","author":"Hawn","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.11.055_bib26","unstructured":"ClinicalTrials.gov. GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation. February 12, 2013. Updated October 29, 2014. Available at:\u00a0http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01813435. Accessed December 5,\u00a02014."}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714074798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714074798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T23:21:18Z","timestamp":1537831278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714074798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0735109714074798"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2014.11.055","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stent Selection and Antiplatelet\u00a0Therapy\u00a0Duration","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.11.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.11.053","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}